title: Treatment complications in neuroblastoma patients: lessons from screening studies.
authors.forename: Reinhold
authors.initials: R
authors.lastname: Kerbl
authors.forename: Christian E
authors.initials: CE
authors.lastname: Urban
authors.forename: Heinz
authors.initials: H
authors.lastname: Zotter
authors.forename: Hans J
authors.initials: HJ
authors.lastname: Dornbusch
authors.forename: Ruth
authors.initials: R
authors.lastname: Ladenstein
authors.forename: Inge M
authors.initials: IM
authors.lastname: Ambros
authors.forename: Peter F
authors.initials: PF
authors.lastname: Ambros
mesh_terms: D000293:Adolescent; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D018450:Disease Progression; D006801:Humans; D033162:Incidental Findings; D008403:Mass Screening; D009447:Neuroblastoma / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents